Cargando…
Knockdown of LRRN1 inhibits malignant phenotypes through the regulation of HIF-1α/Notch pathway in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is one of the most refractory and fatal human malignancies. Leucine-rich repeat neuronal protein-1 (LRRN1) plays a crucial role in the development of the nervous system. However, the clinical implications and biological functions of LRRN1 in PDAC remain unclea...
Autores principales: | Zhang, Yalu, Liu, Qiaofei, Yang, Sen, Liao, Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479295/ https://www.ncbi.nlm.nih.gov/pubmed/34632050 http://dx.doi.org/10.1016/j.omto.2021.08.012 |
Ejemplares similares
-
GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma
por: Yang, Sen, et al.
Publicado: (2022) -
Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2021) -
Up‐regulation of CDHR5 expression promotes malignant phenotype of pancreatic ductal adenocarcinoma
por: Gao, Junyi, et al.
Publicado: (2020) -
Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming
por: Yang, Sen, et al.
Publicado: (2021) -
Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2022)